fbpx Skip to main content


Pauline McNulty, Ph.D.



Pauline McNulty is Vice President, Patient Reported Outcomes, Global Market Access in the Global Commercial Strategy Organization at Janssen.  In this role, she is responsible for ensuring the patient’s perspective is appropriately incorporated into global drug development programs through measurement of Patient Reported Outcomes (PROs). In addition, she leads several internal programs related to talent development in the global market access community at Janssen.

Pauline joined Johnson & Johnson in 1994 as a Director in the Health Economics department. Since that time, she has held positions of broad and increasing responsibility, including Vice President Health Economics, when she was responsible for health economics for all products in development, and Vice President Health Economics & Pricing when she was responsible for market access for products in the Internal Medicine portfolio.

Previously, Pauline worked at Schering-Plough, where she was Director Pharmacoeconomics for Respiratory and Cardiovascular products in development as well as those already on the market. Prior to joining the pharmaceutical industry, she worked for a healthcare research and consulting company, SysteMetrics, in Santa Barbara, California. 

Pauline has been involved in several external initiatives and forums that relate to patient representation and outcomes. In 2009-2010, Pauline served as a member of the Steering Committee for the National Quality Forum’s (NQF) National Voluntary Consensus Standards for Patient Outcomes. Currently, she is a member of the PhRMA Patient Focused Drug Development Work Group and the National Health Council’s Patient Engagement Work Group. Within Janssen, she is a member of the Global Patient Engagement Team, whose mission is to partner with patients and caregivers from an early stage of drug development to maintain an ongoing dialogue to develop solutions that better meet their needs

Pauline received her Ph.D. in experimental psychology from the University of California, Santa Barbara.  She has an Master of Science in Experimental Psychology and a Bachelor of Science in Science from University College Dublin. She has published several articles related to health economics and patient reported outcomes and the patient’s perspective in drug treatment. From 2009- 2011, Pauline participated in Johnson & Johnson’s Health Policy Excellence Program through the Jefferson School of Population Health.